* Predictive Oncology Inc POAI.OQ reported a quarterly
adjusted loss of 5 cents per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 7 cents per share.
* Revenue was $350.21 thousand; analysts expected $600.00
thousand.
* Predictive Oncology Inc's reported EPS for the quarter was a
loss of 5 cents.
* The mean earnings estimate of analysts had risen by about 6.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Predictive Oncology Inc shares had fallen by 16.0% this
quarter and gained 50.2% so far this year.
* The company reported a quarterly loss of $2.57 million.
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 12 at 04:07 a.m. All
figures in US dollars unless otherwise stated